GL1X · GenesisL1 explorer

MolNFT v1 · #33350 · protein

A pharmacological MAP of the PI3-K family defines a role for P110 alpha in signaling: the structure of complex of phosphoinositide 3- kinase gamma with inhibitor pik-39

2CHW · Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic…: “A pharmacological MAP of the PI3-K family defines a role for P110 alpha in signaling: the structure of…”. X-ray diffraction, 1 ligand (039), 14 pockets (best druggability…

PDB
2CHW
Type
protein
Length
840 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
EC
2.7.1.137, 2.7.1.153
UniProt
P48736
Ligands
039
Pockets
14 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (EC 2.7.1.137, 2.7.1.153)protein84044% helix, 17% strandP48736

Ligands and binding sites

  • 039 · 2-((9H-purin-6-ylthio)methyl)-5-chloro-3-(2-methoxyphenyl)quinazolin-4(3H)-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110760.820.8375empty
21080.780.9834empty
34090.680.8145empty
44730.680.7948039
51730.560.8129empty

Compared structures

  • 2CHW · A pharmacological map of the PI3-K family defines a role for p110 alpha in signaling: The… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.